Connect with us
Prague Gaming & TECH Summit 2025 (25-26 March)

Blockchain Press Releases

Piramal Pharma Limited Announces Consolidated Results for Q1FY24

Published

on

piramal-pharma-limited-announces-consolidated-results-for-q1fy24

MUMBAI, India, Aug. 3, 2023 /PRNewswire/ — Piramal Pharma Limited (NSE: PPLPHARMA | BSE: 543635), today announced its consolidated results for the first quarter (Q1) ended 30th June 2023.

 

 

Consolidated Financial Highlights

(In INR Crores)

Advertisement

Particulars

Q1

FY24

Q1

FY23

Advertisement

YoY Growth

Q4

FY23

QoQ Growth

Revenue from Operation

Advertisement

1,749

1,482

18 %

2,164

-19 %

Advertisement

   CDMO

898

770

17 %

1,285

Advertisement

-30 %

   Complex Hospital Generic (CHG)

617

508

22 %

Advertisement

702

-12 %

   India Consumer Healthcare (ICH)

239

211

Advertisement

13 %

206

16 %

EBITDA

171

Advertisement

89#

92 %

376

-55 %

EBITDA Margin

Advertisement

10 %

6 %

17 %

PAT

-99

Advertisement

-109

NA

50

-297 %

PAT Margin

Advertisement

-6 %

-7 %

2 %

# Q1 FY23 EBITDA had one-time inventory margin impact of INR 68 Crore

Key Highlights for Q1FY24

Advertisement
  • Revenue from Operation grew by 18% YoY in Q1FY24 driven by broad base performance across all three businesses – CDMO, CHG and ICH
  • EBITDA margin in Q1FY24 was 10%, a YoY improvement compared to 6% in Q1FY23, driven by healthy revenue growth and cost optimization measures 
  • We maintain our quality track record of zero OAIs (Official Action Indicated) as we successfully closed the US FDA inspection at the Pithampur facility with zero observations
  • We strengthened our Management Team by appointing Jeffrey Hampton as President & Chief Operating Officer for Piramal Critical Care (CHG business)
  • We have shared the details of our Rights Issue – Rights Price of INR. 81, Record Date of August 2, 2023 and Entitlement Ratio of 5:46

Nandini Piramal, Chairperson, Piramal Pharma Limited said, “We had a positive start to the new financial year with healthy revenue growth and improvement in our EBITDA margins. Our CDMO business is also witnessing continued order inflows, especially for our differentiated offerings and innovation related work. Our Inhalation Anesthesia portfolio is seeing a healthy demand and our India Consumer Healthcare business is delivering good growth driven by power brands. We continue to maintain our best-in-class quality track record and are also taking multiple initiatives in the area of ESG to grow our business responsibly.
Historically our H2 has been better than H1, both in terms of revenue and profitability. We are working to leverage our good start to the financial year and continuing this momentum to deliver a healthy YoY performance for the rest of the year. We believe in the growth potential of our business and are accordingly executing on our strategic priorities to create shareholder value. Our promoter and promoter group have agreed to subscribe to the extent of 100% of the equity shares offered in our Rights Issue, thereby reaffirming their confidence in the underlying strengths of our business.”

Key Business Highlights for Q1FY24

 

Contract Development and Manufacturing Organization (CDMO):

  • Witnessed continued order inflow momentum and strong execution in Q1FY24. Continue to see good demand for our differentiated offering in the niche areas of high potent API, peptide, anti-body drug conjugate (ADC) and development and manufacturing of on-patent API
  • Recently expanded capacities at sites with differentiated offering witnessing encouraging customer demand
  • Capacity expansion for antibody drug conjugate (ADC) at Grangemouth facility to strengthen our position in the ADC market
  • YoY improvement in demand for our generic API business
  • Maintained our quality track record – Successfully cleared 8 regulatory inspections (including an US FDA inspection at our Pithampur facility) and multiple customer audits in Q1FY24
  • Cost optimization, strategizing procurement and operational excellence initiatives helping to mitigate inflationary pressures and improve profitability

 

Complex Hospital Generics (CHG):

  • Continued momentum in Inhalation Anesthesia (IA) sales, mainly led by strong demand for Sevoflurane
  • Expanding inhalation anesthesia capacity to meet the growing demand
  • Intrathecal portfolio in the US continue to command leading market share
  • Building a pipeline of 27+ new products which are various stages of development. Launched 1 new product during Q1FY24
  • Appointed Jeffrey Hampton as President & Chief Operating Officer of CHG Business. Jeff has previously worked with Accord Healthcare, Inc. and Apotex Inc.  

 

India Consumer Healthcare (ICH):

Advertisement
  • 11 new products and 3 new SKUs launched during Q1FY24
  • Continue to invest in media and trade spends to drive growth in power brands
  • Power Brands – Littles, Lacto Calamine, Polycrol, Tetmosol and I-range, grew by 15% YoY in Q1FY24 and contribute to 43% of ICH sales
  • E-commerce grew by more than 18% YoY in Q1FY24
  • Wide distribution reach across general trade and are also strengthening our presence in alternate channels of distribution including e-commerce, modern trade, and having our own direct-to-customer website -Wellify.in

 

 

Consolidated Profit and Loss Statement

(In INR Crores)

Reported Financials

Particulars

Advertisement

Q1FY24

Q1FY23

YoY  Change

Q4FY22

QoQ  Change

Advertisement

Revenue from Operations

1,749

1,482

18 %

2,164

Advertisement

-19 %

Other Income

38

72

-47 %

Advertisement

25

56 %

Total Income

1,787

1,554

Advertisement

15 %

2,188

-18 %

Material Cost

627

Advertisement

574

9 %

840

-25 %

Employee Expenses

Advertisement

496

461

8 %

474

5 %

Advertisement

Other Expenses

494

430

15 %

499

Advertisement

-1 %

EBITDA

171

89#

92 %

Advertisement

376

-55 %

Finance Cost

119

62

Advertisement

90 %

104

14 %

Depreciation

174

Advertisement

162

7 %

184

-6 %

Share of net profit of associates

Advertisement

14

20

-28 %

8

85 %

Advertisement

Profit Before Tax

-107

-115

-7 %

95

Advertisement

-213 %

Tax

-9

-6

NA

Advertisement

45

-119 %

Net Profit after Tax

-99

-109

Advertisement

NA

50

-297 %

Exceptional item

0

Advertisement

0

0

Net Profit after Tax after exceptional item

-99

-109

Advertisement

NA

50

-297 %

 # Q1 FY23 EBITDA had one-time inventory margin impact of INR 68 Crore

Q1FY24 Earnings Conference Call

Advertisement

Piramal Pharma Limited will be hosting a conference call for investors / analysts on 4th August 2023 at 10:00 AM (IST) to discuss its Q1FY24 Results. 

The dial-in details for the call are as under:

Event

Location & Time

Telephone Number

Advertisement

Conference call on
4th August, 2023

India – 10:00 AM IST

+91 22 6280 1461 / +91 22 7115 8320 (Primary Number)

1 800 120 1221 (Toll free number)

USA – 12:30 AM

Advertisement

(Eastern Time – New York)

Toll free number

18667462133

UK – 5:30 AM

(London Time)

Advertisement

Toll free number

08081011573

Singapore – 12:30 PM

(Singapore Time)

Toll free number

Advertisement

8001012045

Hong Kong – 12:30 PM

(Hong Kong Time)

Toll free number

800964448

Advertisement

Express Join with Diamond Pass™

Please use this link for prior registration to reduce wait time at the time of joining the call –https://services.choruscall.in/DiamondPassRegistration/register?confirmationNumber=9503078&linkSecurityString=33aa158d84

About Piramal Pharma Ltd:

Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), offers a portfolio of differentiated products and services through its 17 global development and manufacturing facilities and a global distribution network in over 100 countries. PPL includes Piramal Pharma Solutions (PPS), an integrated contract development and manufacturing organization; Piramal Critical Care (PCC), a complex hospital generics business; and the India Consumer Healthcare business, selling over-the-counter products. In addition, one of PPL’s associate companies, Allergan India Private Limited is a JV with AbbVie Inc. and has emerged as one of the market leaders in the ophthalmology therapy area. Further, PPL has a minority investment in Yapan Bio Private Limited. In October 2020, PPL received a 20% strategic growth investment from the Carlyle Group.

For more information visit: www.piramaI.com/pharma I I inker1ln | Facebook I Twitter.

Advertisement

Photo: https://mma.prnewswire.com/media/2169456/Nandini_Piramal.jpg
Logo: https://mma.prnewswire.com/media/1855206/4196563/Piramal_Pharma_Limited_Logo.jpg

 

Piramal Pharma Limited Logo

 

Cision View original content:https://www.prnewswire.co.uk/news-releases/piramal-pharma-limited-announces-consolidated-results-for-q1fy24-301893273.html

Continue Reading
Advertisement

Blockchain Press Releases

Ethiopia-Exclusive: Bybit Livens up P2P Marketplace with 12,000 USDT in Rewards

Published

on

ethiopia-exclusive:-bybit-livens-up-p2p-marketplace-with-12,000-usdt-in-rewards

DUBAI, UAE, Nov. 18, 2024 /PRNewswire/ — Bybit, the world’s second-largest cryptocurrency exchange by trading volume, is pleased to announce an Ethiopia-only limited time offer for Bybit P2P users. From now to Dec. 5, eligible makers and users on Bybit P2P can choose a special rewards track while capturing opportunities in P2P trading.

Registration is required for all three events:

1. Merchant-exclusive Event

On Bybit P2P, users may enter the P2P Maker Battle for a share of a 2,000 USDT prize pool. Merchants may get a share of the prize pool by placing a sell ad in the Ethiopian Birr (ETB) on the Bybit P2P marketplace, inviting others to buy USDT.

The prize pool will be divided by the top 10 merchants who trade with the largest number of unique users, and complete a minimum trading volume of 5,000 USDT and minimum number of 50 unique buyers. To qualify, the Merchant must register and submit their UIDs using this form.

Advertisement

2. Cashback Event: Up to 2% for Existing Users

All buyers have a chance at an easy win from another 8,000 USDT prize pool.  Existing P2P users may simply trade to reach a minimum of 500 USDT in trading volume to unlock 2% cashback, up to 10 USDT per user.

3. Sharers Get More 

Users have another way to access a 2,000 USDT prize pool by using the “share” button to  spread the word about their ETB journey on Bybit P2P. The top 10 participants with the highest views will get to tell their stories and take home the rewards. Interested users may use this form to submit their work.

P2P trading is an organic part of the crypto market and an indispensable tool for improving financial inclusion and interconnectivity between community members. Bybit P2P provides a secure and user-friendly peer-to-peer trading solution, enabling users to seamlessly trade among themselves at zero fees.

Advertisement

Bybit offers resources about posting trades on Bybit P2P, and Ethiopian users may visit here for more.

#Bybit / #TheCryptoArk

About Bybit

Bybit is the world’s second-largest cryptocurrency exchange by trading volume, serving over 50 million users. Established in 2018, Bybit provides a professional platform where crypto investors and traders can find an ultra-fast matching engine, 24/7 customer service, and multilingual community support. Bybit is a proud partner of Formula One’s reigning Constructors’ and Drivers’ champions: the Oracle Red Bull Racing team.

For more details about Bybit, please visit Bybit Press
For media inquiries, please contact: [email protected] 
For more information, please visit: https://www.bybit.com
For updates, please follow: Bybit’s Communities and Social Media

Advertisement

Discord | Facebook | Instagram | LinkedIn | Reddit | Telegram | TikTok | X | Youtube

Bybit Logo

Photo – https://mma.prnewswire.com/media/2559015/Ethiopia_Exclusive_Bybit.jpg
Logo – https://mma.prnewswire.com/media/2267288/Logo.jpg 

Cision View original content:https://www.prnewswire.co.uk/news-releases/ethiopia-exclusive-bybit-livens-up-p2p-marketplace-with-12-000-usdt-in-rewards-302308680.html

Continue Reading

Blockchain

Adapt or Die: The Urgent Shift from VASP to MiCA

Published

on

adapt-or-die:-the-urgent-shift-from-vasp-to-mica

The European Union’s landmark MiCA regulation is set to transform the crypto industry, establishing stringent standards that many current Virtual Asset Service Providers may find challenging to meet. As MiCA compliance becomes the standard for operating within the European Economic Area, crypto exchanges and asset companies must take prompt action to align their operations with these comprehensive regulations.

To support businesses in navigating this significant transition, an exclusive webinar “Adapt or Die: The Urgent Shift from VASP to MiCA” will be held on Tuesday, November 19th, 2024, at 5:00 PM (CET) time.

This session is designed to provide industry professionals with practical insights and strategies to ensure their software and operations comply with MiCA standards.

Key highlights of the webinar include:

Advertisement

● Detailed analysis of MiCA regulations and their implications for the crypto sector.

● Actionable steps for software adaptation to achieve MiCA compliance.

● Case study feature: How Kyrrex achieved MiCA readiness using solutions from Simplify Labs.

● Practical tools for Anti-Money Laundering, Know Your Customer processes, cybersecurity, and transaction monitoring.

The webinar will be useful for CEOs, COOs, Compliance Officers, Regulatory and Legal Professionals, Tech Managers, and Investors looking to enter or expand within the EEA market. Attendees will gain the knowledge and tools necessary to adapt and thrive under the new MiCA regulatory framework.

Advertisement

Featured speakers:

Vadim Rozov, CEO at Simplify Labs, brings over 20 years of management and software development experience. Under his leadership, the company is dedicated to simplifying crypto and blockchain technology, making it accessible for non-technical founders and management teams.

Kevin Plumpton, CEO at Kyrrex, is a warranted advocate with extensive expertise in finance, business, property, and international law. He specializes in corporate governance, risk, and compliance legislation, and is a prominent figure in the Anti-Money Laundering and Counter Financing of Terrorism fields. He is recognized for developing innovative KYC and due diligence platforms utilized by leading organizations.

“The crypto industry is at a critical juncture where understanding and adhering to MiCA regulations is essential for continued growth and market access,” said Kevin Plumpton, CEO at Kyrrex. “Events like these are vital for bringing together industry leaders to share knowledge and best practices, ensuring businesses can adapt effectively and sustain their operations.”

Franklin Cachia, Executive Director at CSB Group, is an accomplished professional who advises clients on taxation, financial services, AML compliance, and corporate law, among other areas. His broad expertise also encompasses gaming, GDPR, and property law.

Advertisement

The post Adapt or Die: The Urgent Shift from VASP to MiCA appeared first on .

Continue Reading

Blockchain Press Releases

Sweat Your Way to Rewards: Live4Well Revolutionizes Wellness with Innovative “Exercise-to-Earn” Ecosystem

Published

on

sweat-your-way-to-rewards:-live4well-revolutionizes-wellness-with-innovative-“exercise-to-earn”-ecosystem

HONG KONG, Nov. 18, 2024 /PRNewswire/ — The past decade has witnessed a dramatic shift in consumer behavior, with online shopping becoming the norm, further accelerated by the pandemic. Reward programs have sprung up everywhere, incentivizing spending and fostering brand loyalty. The core of cashback is to encourage consumers to develop a habit of continuous shopping through rewards. This same logic is beginning to take root in the field of sports and health.

GYMetaverse, the innovative team behind the successful Live4Well Genesis NFT collection, is disrupting the rewards landscape with the launch of its upgraded VIV PASS program. This groundbreaking “move-to-earn” ecosystem incentivizes healthy habits, transforming sweat equity into tangible rewards. Live4Well envisions a positive feedback loop where exercise leads to better health, and better health leads to tangible benefits, realizing the concept of “health as wealth.”

Pioneering the “Fitness Mileage” Concept: Earn Rewards for an Active Lifestyle

This inclusive program is open to users worldwide with zero barriers to entry. In just minutes, users can download the Live4Well mobile app and register for free access to the VIV Pass ecosystem. Initially, Sweat Points, the program’s reward currency, can be earned through three primary avenues:

(1) Daily Exercise — Users accumulate points by tracking steps and calories burned, turning daily workouts into rewarding experiences.

Advertisement

(2) Competition Participation — Points are awarded for participating in designated sporting activities, simply by uploading proof of participation.

(3) Health & Fitness Spending — Users can upload receipts for eligible purchases in the designated sports and wellness categories to earn additional Sweat Points.

Live4Well makes the benefits of exercise immediately tangible, converting effort into visible rewards. Accumulated Sweat Points can be redeemed for a variety of prizes, including cash vouchers, fitness products, and exercise classes. The Live4Well app also empowers users to track their fitness data and participate in engaging challenges.

Creating a Global Sharing Economy: A triple win for Users, Businesses, and the Industry

Live4Well‘s vision extends beyond simply creating a health management platform. The “exercise-to-earn” concept fosters a mutually beneficial ecosystem:

Advertisement

(1) User BenefitsVIV PASS motivates individuals to adopt and maintain healthy exercise habits through a rewarding system.

(2) Business Advantages — The platform connects businesses with their target audience through community engagement and strategic partnerships, driving more effective product promotion.

(3) Industry Transformation — By creating a “move-to-earn” economy, Live4Well stimulates consumer spending, transforming calorie expenditure into a quantifiable reward unit. This innovative approach empowers businesses to generate revenue, expand operations, and seamlessly connect the virtual and physical worlds.

Since its inception, Live4Well‘s fitness alliance ecosystem has continued to expand. With ongoing optimization of its operational framework, the VIV PASS ecosystem provides easy access and a tiered membership system, fostering a comprehensive wellness mechanism which stimulates consumer engagement, and builds a thriving global sharing economy.

To learn more, please visit: https://www.live4well.io

Advertisement
Live4Well VIV PASS

Photo – https://mma.prnewswire.com/media/2560192/Live4Well.jpg
Photo – https://mma.prnewswire.com/media/2560193/Live4Well_Press_Release_Visual_Eng_1.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/sweat-your-way-to-rewards-live4well-revolutionizes-wellness-with-innovative-exercise-to-earn-ecosystem-302308269.html

Continue Reading
Advertisement
 title=
Advertisement

Latest News

Recent Listings

  • Global Payout, Inc.

    Since the Company’s inception in 2009, Global Payout, Inc. has been a leading provider of compreh...

  • MTrac Tech Corp.

    MTrac Tech Corporation, a Nevada Corporation, is a privately held, wholly owned subsidiary of Glo...

  • Net1

    Net1 is a leading provider of transaction processing services, financial inclusion products ...

  • uBUCK Technologies SEZC

    Based in Georgetown, Cayman Islands, uBUCK Tech is a fintech enterprise that specializes in digit...

  • LiteLink Technologies Inc.

      LiteLink is a major player in developing world-class enterprise platforms that utilize ar...

  • Good Gamer Corp.

      Good Gamer Corp. is a privately-held technology company focusing on gamers and streamers....

  • BitPay

      Founded in 2011, BitPay pioneered blockchain payment processing with the mission of trans...

  • About Net1

      Net1 is a leading provider of transaction processing services, financial inclusion produc...

  • Blockchain Foundry Inc.

    Headquartered in Toronto, Canada, Blockchain Foundry (CSE:BCFN)(FWB:8BF)(OTC:BLFDF) is a global b...

  • Sixgill

    Sixgill provides a full suite of universal data automation and authenticity products and services...

Trending on TBE